Analysts Offer Insights on Healthcare Companies: Brookdale Senior Living (BKD), Kyntra Bio (KYNB) and Hims & Hers Health (HIMS)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Brookdale Senior Living (BKD – Research Report), Kyntra Bio (KYNB – Research Report) and Hims & Hers Health (HIMS – Research Report).
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Brookdale Senior Living (BKD)
Barclays analyst Andrew Mok CFA maintained a Buy rating on Brookdale Senior Living today and set a price target of $18.00. The company’s shares closed last Monday at $15.44.
According to TipRanks.com, CFA is a 1-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Brookdale Senior Living with a $19.38 average price target, a 28.6% upside from current levels. In a report issued on February 20, Jefferies also maintained a Buy rating on the stock with a $23.00 price target.
See today’s best-performing stocks on TipRanks >>
Kyntra Bio (KYNB)
William Blair analyst Andy Hsieh reiterated a Hold rating on Kyntra Bio today. The company’s shares closed last Monday at $8.05.
According to TipRanks.com, Hsieh is a 4-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Kyntra Bio.
Hims & Hers Health (HIMS)
KeyBanc analyst Justin Patterson maintained a Hold rating on Hims & Hers Health today. The company’s shares closed last Monday at $15.51, close to its 52-week low of $11.20.
According to TipRanks.com, Patterson is a 4-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Hims & Hers Health with a $32.39 average price target, which is a 105.1% upside from current levels. In a report issued on February 9, Needham also maintained a Hold rating on the stock.
